Insiders · SBTX

SBTX insider transactions

Silverback Therapeutics Inc. (SBTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SBTX

• 892d
  Lowenthal Richard E gifted 2,100,000 shares and received a gift of 2,100,000 shares, decreasing direct ownership by 20% to 4,126,822 units (SEC Form 4)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 892d
  SEC Form 4 filed by Karas Eric

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 892d
  Tanimoto Sarina gifted 2,100,000 shares and received a gift of 2,100,000 shares, decreasing direct ownership by 24% to 3,276,854 units (SEC Form 4)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 892d
  SEC Form 4 filed by Dorsey Brian

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 892d
  SEC Form 4 filed by Chakma Justin

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 892d
  SEC Form 4 filed by Scott Kathleen D.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 892d
  SEC Form 4 filed by Fitzpatrick Alexander A

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 986d
  Fitzpatrick Alexander A bought $319,954 worth of shares (86,258 units at $3.71), increasing direct ownership by 2,905% to 89,227 units (SEC Form 4)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 993d
  SEC Form 4: Ra Capital Management, L.P. bought $8,183,526 worth of shares (2,700,000 units at $3.03)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1012d
  SEC Form 4: Shawver Laura exercised 100,000 shares at a strike of $1.27 and sold $770,520 worth of shares (100,000 units at $7.71)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1018d
  SEC Form 4: Ra Capital Management, L.P. bought $23,250,000 worth of shares (3,750,000 units at $6.20)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1018d
  SEC Form 4: Orbimed Advisors Llc bought $3,100,000 worth of shares (500,000 units at $6.20)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1018d
  SEC Form 4: Thompson Peter A. bought $3,100,000 worth of shares (500,000 units at $6.20)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1042d
  SEC Form 4: Shawver Laura exercised 45,004 shares at a strike of $1.27 and sold $316,489 worth of shares (45,004 units at $7.03)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1046d
  SEC Form 4: Shawver Laura exercised 54,996 shares at a strike of $1.27 and sold $391,841 worth of shares (54,996 units at $7.12)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1072d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1073d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Dadoo Rajeev

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Shah Pratik

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Kelly Michael

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Thompson Peter A.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Schneider Phillip M

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Saunders Brent L

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1081d
  SEC Form 4 filed by Islam Saqib

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1107d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1131d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Scott Kathleen D.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Karas Eric

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Dorsey Brian

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Chakma Justin

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Fitzpatrick Alexander A

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Lowenthal Richard E

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1256d
  SEC Form 4 filed by Tanimoto Sarina

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1283d
  SEC Form 3 filed by new insider Dorsey Brian

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1290d
  SEC Form 3 filed by new insider Fitzpatrick Alexander A

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1291d
  SEC Form 4: Scott Kathleen D. bought $51,506 worth of shares (8,250 units at $6.24)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1311d
  SEC Form 3: New insider Flynn James E claimed ownership of 5,538,964 shares and claimed ownership of 5,538,964 shares

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Ra Capital Management, L.P. was granted 3,009,678 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4 filed by Schneider Phillip M

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4 filed by Karas Eric

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Shah Pratik was granted 10,156,204 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Chakma Justin was granted 236,380 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4 filed by Saunders Brent L

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Tanimoto Sarina was granted 12,199,408 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Lowenthal Richard E was granted 13,049,376 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Dadoo Rajeev was granted 3,009,677 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4 filed by Scott Kathleen D.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 4: Kelly Michael was granted 83,225 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Schneider Phillip M

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Lowenthal Richard E

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Karas Eric

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Shah Pratik

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Kelly Michael

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Leff Jonathan S

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Scott Kathleen D.

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Chakma Justin

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Ra Capital Management, L.P.

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1312d
  SEC Form 3 filed by new insider Dadoo Rajeev

  3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)